Clinical Trial: Amnioinfusion's Protective Effects on Respiratory and Longitudinal Pediatric Outcomes After Intrapartum Thick Meconium Exposure

U.S., Dec. 11 -- ClinicalTrials.gov registry received information related to the study (NCT07274527) titled 'Amnioinfusion's Protective Effects on Respiratory and Longitudinal Pediatric Outcomes After Intrapartum Thick Meconium Exposure' on Nov. 27.

Brief Summary: Thick meconium in the amniotic fluid occurs in about one out of seven pregnancies and increases the chance that a newborn may have breathing problems after birth. These problems can include the need for oxygen, breathing support, admission to the neonatal intensive care unit (NICU), or, in severe cases, meconium aspiration syndrome or persistent pulmonary hypertension.

Although amnioinfusion or placing sterile fluid into the uterus during labor was previously studied as a way to...